Literature DB >> 19288827

The role of surgery in recurrent thymic tumors.

Enrico Ruffini1, Pier Luigi Filosso, Alberto Oliaro.   

Abstract

Surgery plays an important role in treating recurrent thymic tumors. This approach may require both induction therapy and oncological consolidation (adjuvant) in case the lesion shows extended invasion of the surrounding organs. Extended resections are justified to achieve complete removal of the recurrence. Recurring thymic carcinoma or carcinoids may be more difficult to treat.

Entities:  

Mesh：

Year:  2009        PMID： 19288827     DOI： 10.1016/j.thorsurg.2008.09.005

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  8 in total

1.  Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progression.

Authors:  Giuseppe L Banna; Ankur Sheel; Varun Sheel; Andrea Bille; Tom Routledge; Shalini Fernando; Arjun Nair; Rohit Lal
Journal:  Future Oncol       Date:  2017-11-10       Impact factor: 3.404

2.  Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database.

Authors:  Enrico Ruffini; Frank Detterbeck; Dirk Van Raemdonck; Gaetano Rocco; Pascal Thomas; Walter Weder; Alessandro Brunelli; Andrea Evangelista; Federico Venuta
Journal:  Eur J Cardiothorac Surg       Date:  2014-01-30       Impact factor: 4.191

Review 3.  Thymoma and thymic carcinoma.

Authors:  Federico Venuta; Erino A Rendina; Marco Anile; Tiziano de Giacomo; Domenico Vitolo; Giorgio F Coloni
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-01-13

Review 4.  Surgical Approaches for Stage IVA Thymic Epithelial Tumors.

Authors:  Mark Shapiro; Robert J Korst
Journal:  Front Oncol       Date:  2014-01-14       Impact factor: 6.244

Review 5.  The clinical features, diagnosis and management of recurrent thymoma.

Authors:  Taobo Luo; Hongguang Zhao; Xinming Zhou
Journal:  J Cardiothorac Surg       Date:  2016-08-31       Impact factor: 1.637

Review 6.  [Treatment of Recurrent Thymoma].

Authors:  Xianping Liu; Xiao Li; Jianfeng Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-02-27

Review 7.  A narrative review of hyperthermic intrathoracic chemotherapy for advanced lung cancer.

Authors:  Kimberly Song; Raja M Flores
Journal:  Ann Transl Med       Date:  2021-06

8.  Thymoma-associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma.

Authors:  Anna De Rosa; Marco Fornili; Michelangelo Maestri Tassoni; Melania Guida; Laura Baglietto; Loredana Petrucci; Antonio Chella; Franca Melfi; Marco Lucchi; Roberta Ricciardi
Journal:  Thorac Cancer       Date:  2020-11-03       Impact factor: 3.500
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.